Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,891 | -81,678 | -48,722 | 44,622 | 19,589 |
| Depreciation Amortization | 125,352 | 62,331 | 240,948 | 179,351 | 119,784 |
| Accounts receivable | -156,471 | -55,735 | 125,799 | 47,924 | 67,327 |
| Other Working Capital | -68,691 | -11,974 | -47,186 | -100,886 | -66,148 |
| Other Operating Activity | 199,948 | 82,646 | 74,738 | 38,743 | -12,185 |
| Operating Cash Flow | $35,247 | $-4,410 | $345,577 | $209,754 | $128,367 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,764 | -10,060 | -46,801 | -35,009 | -22,533 |
| Purchase Sale Intangibles | -10,450 | -9,700 | -22,388 | -2,488 | -1,488 |
| Other Investing Activity | -5,461 | -9,700 | -22,388 | -2,488 | -1,488 |
| Investing Cash Flow | $-26,225 | $-19,760 | $-69,189 | $-37,497 | $-24,021 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 48,000 | N/A | 219,000 | 110,000 | 100,000 |
| Debt Issued | N/A | 48,000 | 217,732 | N/A | N/A |
| Debt Repayment | -90,373 | -63,377 | -414,080 | -151,510 | -87,566 |
| Common Stock Issued | 386 | 28 | 451 | 408 | N/A |
| Other Financing Activity | -16,254 | -7,806 | -235,676 | -70,639 | -37,590 |
| Financing Cash Flow | $-58,241 | $-23,155 | $-212,573 | $-111,741 | $-25,156 |
| Exchange Rate Effect | -266 | -165 | 65 | -136 | 165 |
| Beginning Cash Position | 99,107 | 99,107 | 35,227 | 35,227 | 35,227 |
| End Cash Position | 49,622 | 51,617 | 99,107 | 95,607 | 114,582 |
| Net Cash Flow | $-49,485 | $-47,490 | $63,880 | $60,380 | $79,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35,247 | -4,410 | 345,577 | 209,754 | 128,367 |
| Capital Expenditure | -20,764 | -10,060 | -46,801 | -35,009 | -22,533 |
| Free Cash Flow | 14,483 | -14,470 | 298,776 | 174,745 | 105,834 |